Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate clinical and laboratory safety associated with the administration of GVAX leukemia vaccine and to determine the feasibility of generation of GVAX leukemia vacc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cell Genesys
NCT06656494 · Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
NCT06859424 · AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), and more
NCT07347171 · Leukemia, AML, and more
NCT07254312 · AML (Acute Myelogenous Leukemia
NCT02143830 · Fanconi Anemia, Severe Marrow Failure, and more
University of California, San Francisco
San Francisco, California
University of Chicago
Chicago, Illinois
Johns Hopkins University
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions